Clinical Trials Directory

Trials / Conditions / Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

9 registered clinical trials studyying Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
NCT07386002
T-MAXIMUM Pharmaceutical IncPhase 2
Not Yet RecruitingNovel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
NCT07416188
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1 / Phase 2
Enrolling By InvitationClinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Gliobl
NCT07520214
Beijing Neurosurgical InstituteEARLY_Phase 1
RecruitingFeasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
NCT07111195
Juan M Garcia-Gomez—
RecruitingStudy of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
NCT06430424
University Hospital, Bordeaux—
RecruitingEvaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
NCT05879367
Orbus Therapeutics, Inc.Phase 1
RecruitingA Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Gli
NCT05765812
Debiopharm International SAPhase 1 / Phase 2
SuspendedStudy of Niacin in Glioblastoma
NCT04677049
AHS Cancer Control AlbertaPhase 1 / Phase 2
CompletedBIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and
NCT05375318
Juan M Garcia-Gomez—